Edition:
United Kingdom

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.50USD
16 Feb 2018
Change (% chg)

$-0.22 (-3.85%)
Prev Close
$5.72
Open
$5.67
Day's High
$5.83
Day's Low
$5.36
Volume
31,846
Avg. Vol
61,638
52-wk High
$14.09
52-wk Low
$4.77

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 1.62 2.30 1.00 --
Quarter Ending Jun-18 4 1.62 2.40 0.80 --
Year Ending Dec-18 7 5.43 9.50 2.90 4.25
Earnings (per share)
Quarter Ending Mar-18 4 -0.57 -0.48 -0.63 --
Quarter Ending Jun-18 4 -0.56 -0.48 -0.63 --
Year Ending Dec-18 7 -2.29 -1.85 -2.86 -9.79
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 50.61 110.72 5.77
Price to Book (MRQ) 0.46 13.56 5.41
Price to Tangible Book (MRQ) 6.16 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 61.24 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.12 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -13.83 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.69 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -8.57 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 3.77 5.30 2.97
LT Debt to Equity (MRQ) 0.44 22.82 12.22
Total Debt to Equity (MRQ) 0.44 24.47 16.52
Interest Coverage (TTM) -2.14 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -290.58 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -987.15 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -991.86 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -1,003.38 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -982.39 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 101,814 22,602,121 855,667,832
Net Income/Employee (TTM) -1,000,203 2,968,747 100,655,557
Receivable Turnover (TTM) 0.73 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.07 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.01 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -87.80 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -88.10 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 24 53
13 Week -20.95 -24.80 18 62
26 Week -24.27 -30.03 24 77
52 Week 15.92 -1.75 60 50
YTD 39.26 22.30 68 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.00%
# of Holders: 54
Total Shares Held: 24,951,800
3 Mo. Net Change: 80,474
# New Positions: 21
# Closed Positions: 13
# Increased Positions: 30
# Reduced Positions: 19
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.